Alcohol and Psychiatric Comorbidity

  • Jack R. Cornelius
  • Oscar Bukstein
  • Ihsan Salloum
  • Duncan Clark
Part of the Recent Developments in Alcoholism book series (RDIA, volume 16)

Abstract

Comorbid psychiatric disorders and drug use disorders (DUDs) are common among alcoholics (Regier, Farmer, Rae, Locke, Keith, Judd, & Goodwin, 1990; Kessler, McGonagle, Zhao, Nelson, Hughes, Eshleman, Wittchen, & Kendler, 1994). These comorbid disorders often predict a shorter time to relapse of alcoholism (Greenfield, Weiss, Muenz, Vagge, Kelly, Bello, & Michael, 1998). However, despite the prevalence and the adverse effects of this comorbidity, few controlled treatment studies have been conducted involving this dual diagnosis population (Litten & Allen, 1999). To date, most of these few studies of alcoholics with comorbid disorders have been restricted to studies of alcoholics with either comorbid major depression or comorbid anxiety disorders (Litten & Allen, 1995). The results of these trials suggest efficacy for SSRI antidepressants and tricyclic antidepressants for treating alcoholics with comorbid major depression and suggest efficacy for buspirone for treating alcoholics with comorbid anxiety disorders (Mason, Kocsis, Ritvo, & Cutler, 1996; Cornelius, Salloum, Ehler, Jarrett, Cornelius, Perel, Thase, & Black, 1997; Kranzler, Burleson, Del Boca, Babor, Korner, Brown, & Bohn, 1994). However, controlled treatment studies involving alcoholics with other comorbid disorders are almost totally lacking. Consequently, to date, no empirically proven treatment exists for most of these comorbid disorders.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Anthony, J.C., Warner, L.A., & Kessler, R.C. (1994). Comparative epidemiology of dependence on tobacco, alcohol, and controlled substances and inhalants: Basic findings from the National Comorbidity Survey. Experimental and Clinical Psychopharmacology 2, 244–268.CrossRefGoogle Scholar
  2. Batki, S.L., Manfredi, L.B., Jacob, P., & Jones, R.T. (1993). Fluoxetine for cocaine dependence in methadone maintenance: Quantitative plasma and urine cocaine benzoylecgonine concentrations. Journal of Clinical Psychopharmacology 13, 243–250.PubMedGoogle Scholar
  3. Bowden, C.L., Brugger, A.M., Suann, A.C., Calabrese, J.R., Janicak, P.G., Petty, F, Dilsaver, S.C., Davis, J.M., Rush, A.J., Smally, J.G., Garza-Trevino, E.S., Risch, C, Goodnick, P.J., & Morris, D.D. (1994). Efficacy of divalproex vs. lithium and placebo in the treatment of mania. Journal of the American Medical Association 271, 918–924.PubMedCrossRefGoogle Scholar
  4. Brady, K.T., Halligan, P., & Malcolm, R.J. (1999). Dual diagnosis. In M. Galanter & H.D. Kleber (eds.), Textbook of Substance Abuse Treatment, 2nd ed., Washington, DC: The American Psychiatric Press, pp. 475–483.Google Scholar
  5. Brady, K.T., Sonne, S.C., Anton, R., & Ballenger, J.C. (1995). Valproate in the treatment of acute bipolar affective episodes complicated by substance abuse: A pilot study. Journal of Clinical Psychiatry 56, 118–121.PubMedGoogle Scholar
  6. Bruno, F. (1989). Buspirone treatment of alcoholic patients. Psychopathology 22, 49–59.PubMedCrossRefGoogle Scholar
  7. Bukstein, O.G., Glancy, L.J., & Kaminer, Y. (1989). Comorbidity of substance abuse and other psychiatric disorders in adolescents. American Journal of Psychiatry 146, 1131–1141.PubMedGoogle Scholar
  8. Clark, D.B., Parker, A.M., & Lynch, K.G. (1999). Psychopathology and substance-related problems during early adolescence: A survival analysis. Journal of Clinical Child Psychology 28, 333–341.PubMedCrossRefGoogle Scholar
  9. Clark, D.B., Pollock, N.K., Bukstein, O.G., Mezzich, A.C., Bromberger, J.T., & Donovan, J.E. (1997). Gender and comorbid psychopathology in adolescents with alcohol dependence. Journal of the American Academy of Child and Adolescent Psychiatry 36, 1195–1203.PubMedGoogle Scholar
  10. Cornelius, J.R., Bukstein, O.G., Birmaher, B., Salloum, I.M., Lynch, K., Pollock, N.K., Gershon, S., & Clark, D.B. (2001). Fluoxetine in adolescents with major depression and an alcohol use disorder: An open label trial. Addictive Behaviors 26, 735–739.PubMedGoogle Scholar
  11. Cornelius, J.R., Fabrega, H., Cornelius, M.D., Mezzich J.E., Maher P.J., Salloum, I.M., Thase, M.E., & Ulrich, R.F. (1996). Racial effects on the clinical presentation of alcoholics at a psychiatric hospital. Comprehensive Psychiatry 37, 102–108.PubMedCrossRefGoogle Scholar
  12. Cornelius, J.R., Jarrett, P.J., Thase, M.E., Fabrega, H., Haas, G.L., Jones-Barlock, J., Mezzich, J.E., & Ulrich, R.F. (1995). Gender effects on the clinical presentation of alcoholics at a psychiatric hospital. Comprehensive Psychiatry 36, 1–7.Google Scholar
  13. Cornelius, J.R., Perkins, K.A., Salloum, I.M., Thase, M.E., & Moss, H.B. (1999). Fluoxetine versus placebo to decrease the smoking of depressed alcoholic patients. Journal of Clinical Psychopharmacology 19, 183–184.PubMedCrossRefGoogle Scholar
  14. Cornelius, J.R., Pringle, J., Jernigan J., Kirisci, L., & Clark, D.B. (2001). Correlates of mental health service utilization and unmet need among a sample of male adolescents. Addictive Behaviors 26, 11–19.PubMedGoogle Scholar
  15. Cornelius, J.R., Salloum, I.M., Cornelius, M.D., Perel, J.M., Thase, M.E., Ehler, J.G., & Mann, J.J. (1993). Fluoxetine trial in suicidal depressed alcoholics. Psychopharmacology Bulletin 29, 195–199.PubMedGoogle Scholar
  16. Cornelius, J.R., Salloum, I.M., Mezzich, J.E., Cornelius, M.D., Fabrega, H., Ehler, J.G., Ulrich, R.F., Thase, M.E., & Mann, J.J. (1995). Disproportionate suicidality in patients with comorbid major depression and alcoholism. American Journal of Psychiatry 152, 358–364.PubMedGoogle Scholar
  17. Cornelius, J.R., Salloum I.M., Day, N.L., Thase, M.E., & Mann, J.J. (1996). Patterns of suicidality and alcohol use in alcoholics with major depression. Alcoholism: Clinical and Experimental Research 20, 1451–1455.Google Scholar
  18. Cornelius, J.R., Salloum, I.M., Ehler, J.G., Jarrett, P.J., Cornelius, M.D., Perel, J.M., Thase, M.E., & Black, A. (1997). Fluoxetine in depressed alcoholics: A double-blind, placebo-controlled trial. Archives of General Psychiatry 54, 700–705.PubMedGoogle Scholar
  19. Cornelius, J.R., Salloum, I.M., Thase, M.E., Haskett, R.F., Daley, D.C., Jones-Barlock, A., Upsher, C, & Perel, J.M. (1998). Fluoxetine versus placebo in depressed alcoholic cocaine abusers. Psychopharmacology Bulletin 34, 117–121.PubMedGoogle Scholar
  20. Cornelius, J.R., Salloum, I.M., Haskett, R.F., Ehler, J.G., Jarrett, P.J., Thase, M.E., & Perel, J.M. (1999). Fluoxetine versus placebo for the marijuana use of depressed alcoholics. Addictive Behaviors 24, 111–114.PubMedCrossRefGoogle Scholar
  21. Cornelius, J.R., Salloum, I.M., Haskett, R.F., Daley, D.C., Cornelius, M.D., Thase, M.E., & Perel, J.M. (2000). Fluoxetine versus placebo in depressed alcoholics: A one-year follow-up study. Addictive Behaviors 25, 307–310.PubMedCrossRefGoogle Scholar
  22. Cornelius, J.R., Salloum, I.M., Lynch, K., Clark, D.B., & Mann, J.J. (2001). Treating the substance-abusing suicidal patient. In H. Hendin & J.J. Mann (eds.), The Annals of the New York Academy of Sciences, 932, 78–93.Google Scholar
  23. Cornelius, J.R., Thase, M.E., Salloum, I.M., Cornelius, M.D., Black, A., & Mann, J.J. (1998). Cocaine use associated with increased suicidal behavior in depressed alcoholics. Addictive Behaviors 23, 119–121.PubMedCrossRefGoogle Scholar
  24. Dorus, W., Ostrow, D.G., Anton, R., Cushman, P., Collins, J.F., Schaefer, V., Charles, H.L., Desai, P., Hayashida, M., Malkerneker, U., Willenbring, M., Fiscella, R., & Sather, M.R. (1989). Lithium treatment of depressed and nondepressed alcoholics. Journal of the American Medical Association 262, 1646–1652.PubMedCrossRefGoogle Scholar
  25. Emslie, G.J., Rush, A.J., Weinberg, W.A., Kowatch, R.A., Hughes, C.W., Carmody, T., & Rintelmann, J. (1997). A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression. Archives of General Psychiatry 54, 1031–1037.PubMedGoogle Scholar
  26. Fawcett, J., Clark, D.L., Aagesen, C.A., Pinasi, V.D., Tilkin, J.M., Sellers, D., McGuire, M., & Gibbons, R.D. (1987). A double-blind, placebo-controlled trial of lithium carbonate therapy for alcoholism. Archives of General Psychiatry 44, 248–256.PubMedGoogle Scholar
  27. George, D.T., Rawlings, R., Eckardt, M.J., Phillips, M.J., Shoaf, S.E., & Linnoila, M. (1999). Buspirone treatment of alcoholism: Age of onset and cerebrospinal fluid 5-hydroxyindolacetic acid and homovanillic acid concentrations, but not medication treatment, predict return to drinking. Alcoholism: Clinical and Experimental Research 23, 272–278.Google Scholar
  28. Greenfield, S.F., Weiss, R.D., Muenz, L.R., Vagge, L.M., Kelly, J.F., Bello, L.R., & Michael, J. (1998). The effect of depression on return to drinking. Archives of General Psychiatry 55, 259–265.PubMedCrossRefGoogle Scholar
  29. Helzer, J.E., & Pryzbeck, T.R. (1998). The co-occurrence of alcoholism and other psychiatric disorders in the general population and its impact on treatment. Journal of Studies on Alcohol 49, 219–244.Google Scholar
  30. Kessler, R.C., Crum, R.M., Warner, L.A., Nelson, C.B., Schulenberg, J., & Anthony, J.C. (1997). Lifetime co-occurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the National Comorbidity Survey. Archives of General Psychiatry 54, 313–321.PubMedGoogle Scholar
  31. Kessler, R.C., McGonagle, K.A., Zhao, S., Nelson, C.B., Hughes, M., Eshleman, S., Wittchen, H.U., & Kendler, K.S. (1994). Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Archives of General Psychiatry 51, 8–19.PubMedGoogle Scholar
  32. King, C.A., Naylor, M.W., Hill, E.M., Shain, B.N., & Greden, J.F. (1993). Dysthymia characteristic of heavy alcohol use in depressed adolescents. Biological Psychiatry 33, 210–212.PubMedCrossRefGoogle Scholar
  33. Kranzler, H.R., Burleson, J.A., Del Boca, F.K., Babor, T.F., Korner, P., Brown, J., & Bohn, M. (1994). Buspirone treatment of anxious alcoholics. Archives of General Psychiatry 51, 720–731.PubMedGoogle Scholar
  34. Kranzler, H.R., Burleson, J.A., Korner, P., Del Boca, F.K., Bohn, M.J., Brown, J., & Liebowitz, N. (1995). Placebo-controlled trial of fluoxetine as an adjunct to relapse prevention in alcoholics. American Journal of Psychiatry 152, 391–397.PubMedGoogle Scholar
  35. Litten, R.Z., & Allen, J.P. (1995). Pharmacotherapy for alcoholics with collateral depression or anxiety: An update of research findings. Experimental and Clinical Psychopharmacology 3, 87–93.CrossRefGoogle Scholar
  36. Litten, R.Z., & Allen, J.P. (1998). Pharmacologic treatment of alcoholics with collateral depression: Issues and future directions. Psychopharmacology Bulletin 34, 107–110.PubMedGoogle Scholar
  37. Litten, R.Z., & Allen, J.P. (1999). Medications for alcohol, illicit drug, and tobacco dependence: An update of research findings. Journal of Substance Abuse Treatment 16, 105–112.PubMedCrossRefGoogle Scholar
  38. Litten, R.Z., & Fertig, J. (1996). International update: New findings on promising medications. Alcoholism: Clinical and Experimental Research 20(Suppl), 216A–218A.Google Scholar
  39. Malcolm, R., Anton, R.F., Randall, C.L., Johnston, A., Brady, K., & Thevos, A. (1992). A placebo-controlled trial of buspirone in anxious inpatient alcoholics. Alcoholism: Clinical and Experimental Research 16, 1007–1013.Google Scholar
  40. Malec, E., Malec, T., Gagne, M.A., & Dongier, M. (1996). Buspirone in the treatment of alcohol dependence: A placebo-controlled trial. Alcoholism: Clinical and Experimental Research 20, 307–312.Google Scholar
  41. Martin, C.S., Kaczynski, N.A., Maisto, S.A., Bukstein, O.G., & Moss, H.B. (1995). Patterns of DSM-IV alcohol abuse and dependence symptoms in adolescent drinkers. Journal of Studies on Alcohol 56, 672–680.PubMedGoogle Scholar
  42. Mason, B.J., Kocsis, J.H., Ritvo, C.E., & Cutler, R.B. (1996). A double-blind, placebo-controlled trial of desipramine for primary alcohol dependence stratified on the presence or absence of major depression. Journal of the American Medical Association 275, 761–767.PubMedCrossRefGoogle Scholar
  43. McGrath, P.J., Nunes, E.V., Stewart, J.W., Goldman, D., Agosti, V., Ocepek-Welikson, K., & Quitkin, P.M. (1996). Imipramine treatment of alcoholics with major depression: A placebo-controlled clinical trial. Archives of General Psychiatry 53, 232–240.PubMedGoogle Scholar
  44. McLellan, A.T., Luborsky, L., Woody, G.E., O’Brien, C.P., & Druley, K.A. (1983). Predicting response to alcohol and drug abuse treatments. Archives of General Psychiatry 40, 620–625.PubMedGoogle Scholar
  45. Naranjo, C.A., Kadlec, K.E., Sanhueza, P., Woodley-Remus, D., & Sellers, E.M. (1990). Fluoxetine differentially alters alcohol intake and other consummatory behaviors in problem drinkers. Clinical Pharmacology and Therapeutics 47, 490–498.PubMedGoogle Scholar
  46. Nunes, E.V., McGrath, P.F., Quitkin, F.M., Stewart, J.W., Goehl, L., & Ocepek-Welikson, K. (1996). Predictors of antidepressant response in depressed alcoholic patients. American Journal of Addiction 5, 308–312.Google Scholar
  47. O’Malley, S.S., & Carroll, K.M. (1996). Psychotherapeutic considerations in pharmacological trials. Alcoholism: Clinical and Experimental Research 20, 17A–22A.Google Scholar
  48. Paille, F.M., Guelfi, J.D., Perkins, A.C., Royer, R.J., Steru, L., & Parot, P. (1995). Double-blind randomized multicenter trial of acamprosate in maintaining abstinence from alcohol. Alcohol and Alcoholism 30, 239–247.PubMedGoogle Scholar
  49. Powell, B.J., Campbell, J.L., Landon, J.F., Liskou, B.I., Thomas, H.M., Nickel, E.J., Dale, T.M., Penick, E.C., Samuelson, S.D., & Lacoursiere, R.B. (1995). A double-blind, placebo-controlled study of nortriptyline and bromocriptine in male alcoholics subtyped by comorbid psychiatric disorders. Alcoholism: Clinical and Experimental Research 19, 462–468.Google Scholar
  50. Project MATCH Research Group. (1998). Matching alcoholism treatments to client heterogeneity: Project MATCH three-year drinking outcomes. Alcoholism: Clinical and Experimental Research 22, 1300–1311.Google Scholar
  51. Regier, D.A., Farmer, M.E., Rae, D.E., Locke, B.Z., Keith, E.J., Judd, L.L., & Goodwin, F.K. (1990). Comorbidity of mental disorders with alcohol and other drug abuse: Results from the Epidemiologic Catchment Area (ECA) study. Journal of the American Medical Association 264, 2511–2518.PubMedCrossRefGoogle Scholar
  52. Riggs, P.D., Mikulich, S.K., Coffman, L.M., & Crowley, T.J. (1997). Fluoxetine in drug-dependent delinquents with major depression: An open trial. Journal of Child and Adolescent Psychopharmacology 7, 87–95.PubMedCrossRefGoogle Scholar
  53. Roy A. (1998). Placebo-controlled study of sertraline in depressed recently abstinent alcoholics. Biological Psychiatry 44, 633–637.PubMedGoogle Scholar
  54. Salloum, I.M., Cornelius, J.R., Thase, M.E., Daley, D.C., Kirisci, L., & Spotts, C. (1998). Naltrexone utility in depressed alcoholics. Psychopharmacology Bulletin 34, 111–115.PubMedGoogle Scholar
  55. Salloum, I.M., Cornelius, J.R., Mezzich, J.E., Kirisci, L., Daley, D.C., Spotts, C.R., & Zuckoff, A. (2001). Characterizing female bipolar alcoholic patients presenting for initial evaluation. Addictive Behaviors 26, 341–348.PubMedCrossRefGoogle Scholar
  56. Tollefson, G.D., Montague-Clouse, J., & Tollefson, S.L. (1992). Treatment of comorbid generalized anxiety in a recently detoxified alcoholic population with a selective serotonergic drug (buspirone). Journal of Clinical Psychopharmacology 12, 19–26.PubMedGoogle Scholar
  57. Vitiello, B., & Jensen, P.S. (1997). Medication development and testing in children and adolescents. Archives of General Psychiatry 54, 871–876.PubMedGoogle Scholar
  58. Volpicelli, J.R., Alterman, A.I., Hayashida, M., & O’Brien, C.P. (1992). Naltrexone in the treatment of alcohol dependence. Archives of General Psychiatry 49, 876–880.PubMedGoogle Scholar
  59. Wilkins, J.N. (1997). Pharmacotherapy of schizophrenia patients with comorbid substance abuse. Schizophrenia Bulletin 23, 215–228.PubMedGoogle Scholar

Copyright information

© Kluwer Academic Publishers 2002

Authors and Affiliations

  • Jack R. Cornelius
    • 1
  • Oscar Bukstein
    • 1
  • Ihsan Salloum
    • 1
  • Duncan Clark
    • 1
  1. 1.Pittsburgh Adolescent Alcohol Research Center, Center for Education and Drug Abuse ResearchUniversity of PittsburghPittsburgh

Personalised recommendations